World Health Organization: For the first time, two vaccines specifically designed against Ebola Bundibugyo virus have now entered phase one safety trials in humans. In addition, two new animal studies of the vaccine against Zaire ebolavirus – the more common species – have shown promising evidence of cross protection in animals.